Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
5
×
life sciences
national blog main
fda
national top stories
novartis
san francisco top stories
boston blog main
boston top stories
clinical trials
eli lilly
gene therapy
national
roche
san francisco blog main
avapritinib
biogen
blueprint medicines
boston
europe top stories
indiana blog main
indiana top stories
medullary thyroid cancer
new york top stories
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
zolgensma
10x genomics
abbvie
acute lymphoblastic leukemia
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
What
fda
drug
therapy
approval
blueprint
cancer
medicines
new
regulatory
ret
roche
address
approved
approves
atrophy
august
bio
biotech
busy
candidate
carries
certain
chemistry
cmc
consistent
controls
currently
daily
days
decisions
designed
devices
drugs
ensure
evrysdi
friday
gene
genetic
green
home
Language
unset
5
×
Current search:
genentech
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More